1. Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother 2012;46(2):169-175. PMID:
22253191.
2. Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, et al. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007;16(12):1275-1284. PMID:
17955500.
3. Park IW, Sheen SS, Yoon D, Lee SH, Shin GT, Kim H, et al. Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring? J Clin Pharm Ther 2014;39(1):61-68. PMID:
24262001.
4. Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998;5(3):305-314. PMID:
9609500.
5. Haerian K, Varn D, Vaidya S, Ena L, Chase HS, Friedman C. Detection of pharmacovigilance-related adverse events using electronic health records and automated methods. Clin Pharmacol Ther 2012;92(2):228-234. PMID:
22713699.
6. Hannan TJ. Detecting adverse drug reactions to improve patient outcomes. Int J Med Inform 1999;55(1):61-64. PMID:
10471241.
7. Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 1988;319(1):24-33. PMID:
3288867.
8. Kim HS, Kim H, Lee H, Park B, Park S, Lee SH, et al. Analysis and comparison of statin prescription patterns and outcomes according to clinical department. J Clin Pharm Ther 2016;41(1):70-77. PMID:
26791968.
9. Kim HS, Lee H, Park B, Park S, Kim H, Lee SH, et al. Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea. Int J Clin Pharmacol Ther 2016;54(11):864-871. PMID:
27487366.
10. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(25 Suppl 2):S1-S45. PMID:
24222016.
11. Kim HS, Lee SH, Kim H, Lee SH, Cho JH, Lee H, et al. Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea. J Clin Pharm Ther 2016;41(3):266-272. PMID:
27015878.
12. Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990;11(2):272-276. PMID:
2254635.
13. Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 2004;109(23 Suppl 1):III50-III57. PMID:
15198967.
14. Tantikul C, Dhana N, Jongjarearnprasert K, Visitsunthorn N, Vichyanond P, Jirapongsananuruk O. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children. Asian Pac J Allergy Immunol 2008;26(2-3):77-82. PMID:
19054924.
15. Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341(7):498-511. PMID:
10441607.
16. Bhardwaj SS, Chalasani N. Lipid-lowering agents that cause drug-induced hepatotoxicity. Clin Liver Dis 2007;11(3):597-613. PMID:
17723922.
17. Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, Chalasani N, Bonkovsky HL. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. Hepatology 2014;60(2):679-686. PMID:
24700436.
18. Farmer JA, Torre-Amione G. Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf 2000;23(3):197-213. PMID:
11005703.
19. Tolman KG. Defining patient risks from expanded preventive therapies. Am J Cardiol 2000;85(12A):15E-19E.
20. Sniderman AD. Is there value in liver function test and creatine phosphokinase monitoring with statin use? Am J Cardiol 2004;94(9A):30F-34F. PMID:
15219504.
21. Reuben A, Koch DG, Lee WM. Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52(6):2065-2076. PMID:
20949552.
22. Russo MW, Scobey M, Bonkovsky HL. Drug-induced liver injury associated with statins. Semin Liver Dis 2009;29(4):412-422. PMID:
19826975.
23. Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, et al. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 2007;63(3):221-228. PMID:
17225990.
24. Bagheri H, Michel F, Lapeyre-Mestre M, Lagier E, Cambus JP, Valdiguie P, et al. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol 2000;50(5):479-484. PMID:
11069443.
25. Robb MA, Racoosin JA, Sherman RE, Gross TP, Ball R, Reichman ME, et al. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf 2012;21(Suppl 1):9-11. PMID:
22262587.
26. Yoon D, Park MY, Choi NK, Park BJ, Kim JH, Park RW. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm. Clin Pharmacol Ther 2012;91(3):467-474. PMID:
22237257.
27. Klintmalm GB, Iwatsuki S, Starzl TE. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 1981;32(6):488-489. PMID:
7041349.
28. Wagoner LE, Olsen SL, Bristow MR, O'Connell JB, Taylor DO, Lappe DL, et al. Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity. Transplantation 1993;56(6):1415-1418. PMID:
8279012.
29. Sai K, Hanatani T, Azuma Y, Segawa K, Tohkin M, Omatsu H, et al. Development of a detection algorithm for statin-induced myopathy using electronic medical records. J Clin Pharm Ther 2013;38(3):230-235. PMID:
23530940.
30. Warrer P, Hansen EH, Juhl-Jensen L, Aagaard L. Using text-mining techniques in electronic patient records to identify ADRs from medicine use. Br J Clin Pharmacol 2012;73(5):674-684. PMID:
22122057.